Cellectar Biosciences, Inc. — Director's Dealing 2023

Dec 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2023-12-08

Reporting Person: Shustov Andrei (Senior Vice President, Medical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-08	Common Stock	A	47856	—	Acquired	55037.7	Direct